|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received May 19, 2004
Revised May 24, 2004
Accepted after revision June 4, 2004
1 University of Alberta
2 Univeristy of Alberta
3 University of Alberta/ Cross Cancer Institute
4 School of Biochemistry and Microbiology, University of Leeds
5 Unversity of Alberta
* To whom correspondence should be addressed. E-mail: james.young{at}ualberta.ca.
Human concentrative nucleoside transporter 1 (hCNT1)
mediates active transport of nucleosides and anticancer
and antiviral nucleoside drugs across cell membranes by
coupling influx to the movement of Na+ down its
electrochemical gradient. The two-microelectrode voltage
clamp was used to measure steady-state and presteady-state
currents of recombinant hCNT1 produced in Xenopus
oocytes. Transport was electrogenic, phloridzin-sensitive
and specific for pyrimidine nucleosides and adenosine.
Nucleoside analogs that induced inwardly-directed
Na+ currents included the anticancer drugs
5-fluorouridine, 5-fluoro-2'deoxyuridine, cladribine and
cytarabine, the antiviral drugs zidovudine and
zalcitabine, and the novel thymidine mimics
1-(2-deoxy-
-D-ribofuranosyl)-2,4-difluoro-5-methylbenzene
and
1-(2-deoxy-
-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene.
5-Fluorouridine, 5-fluoro-2'-deoxyuridine and zidovudine
apparent Km values were 18, 15 and 450 µM,
respectively. hCNT1 was Na+-specific, and the
kinetics of steady-state uridine-evoked Na+
currents were consistent with an ordered simultaneous
transport model in which Na+ binds first
followed by uridine. Membrane potential influenced both
ion-binding and carrier translocation. The
Na+/nucleoside coupling stoichiometry,
determined directly by comparing the uridine-induced
inward charge movement to 14C-uridine uptake
was 1:1. hCNT1 presteady-state currents were used to
determine the fraction of the membrane field sensed by
Na+ (61%), the valence of the movable charge
(-0.81) and the average number of transporters present in
the oocyte plasma membrane (6.8 x 1010 per
cell). The hCNT1 turnover rate at -50 mV was 9.6
molecules of uridine transported per s.
This article has been cited by other articles:
![]() |
M. D. Slugoski, K. M. Smith, R. Mulinta, A. M. L. Ng, S. Y. M. Yao, E. L. Morrison, Q. O. T. Lee, J. Zhang, E. Karpinski, C. E. Cass, et al. A Conformationally Mobile Cysteine Residue (Cys-561) Modulates Na+ and H+ Activation of Human CNT3 J. Biol. Chem., September 5, 2008; 283(36): 24922 - 24934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Slugoski, A. M. L. Ng, S. Y. M. Yao, K. M. Smith, C. C. Lin, J. Zhang, E. Karpinski, C. E. Cass, S. A. Baldwin, and J. D. Young A Proton-mediated Conformational Shift Identifies a Mobile Pore-lining Cysteine Residue (Cys-561) in Human Concentrative Nucleoside Transporter 3 J. Biol. Chem., March 28, 2008; 283(13): 8496 - 8507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. M. Yao, A. M. L. Ng, M. D. Slugoski, K. M. Smith, R. Mulinta, E. Karpinski, C. E. Cass, S. A. Baldwin, and J. D. Young Conserved Glutamate Residues Are Critically Involved in Na+/Nucleoside Cotransport by Human Concentrative Nucleoside Transporter 1 (hCNT1) J. Biol. Chem., October 19, 2007; 282(42): 30607 - 30617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ravera, L. V. Virkki, H. Murer, and I. C. Forster Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements Am J Physiol Cell Physiol, August 1, 2007; 293(2): C606 - C620. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Errasti-Murugarren, M. Pastor-Anglada, and F. J. Casado Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs J. Physiol., August 1, 2007; 582(3): 1249 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D.F. Loo, B. A. Hirayama, M. H. Karakossian, A.-K. Meinild, and E. M. Wright Conformational Dynamics of hSGLT1 during Na+/Glucose Cotransport J. Gen. Physiol., December 1, 2006; 128(6): 701 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Larrayoz, A. Fernandez-Nistal, A. Garces, E. Gorraitz, and M. P. Lostao Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1395 - C1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, K. M. Smith, T. Tackaberry, X. Sun, P. Carpenter, M. D. Slugoski, M. J. Robins, L. P. C. Nielsen, I. Nowak, S. A. Baldwin, et al. Characterization of the Transport Mechanism and Permeant Binding Profile of the Uridine Permease Fui1p of Saccharomyces cerevisiae J. Biol. Chem., September 22, 2006; 281(38): 28210 - 28221. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Aymerich, F. Foufelle, P. Ferre, F. J. Casado, and M. Pastor-Anglada Extracellular adenosine activates AMP-dependent protein kinase (AMPK) J. Cell Sci., April 15, 2006; 119(8): 1612 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, K. M. Smith, T. Tackaberry, F. Visser, M. J. Robins, L. P. C. Nielsen, I. Nowak, E. Karpinski, S. A. Baldwin, J. D. Young, et al. Uridine Binding and Transportability Determinants of Human Concentrative Nucleoside Transporters Mol. Pharmacol., September 1, 2005; 68(3): 830 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Smith, M. D. Slugoski, S. K. Loewen, A. M. L. Ng, S. Y. M. Yao, X.-Z. Chen, E. Karpinski, C. E. Cass, S. A. Baldwin, and J. D. Young The Broadly Selective Human Na+/Nucleoside Cotransporter (hCNT3) Exhibits Novel Cation-coupled Nucleoside Transport Characteristics J. Biol. Chem., July 8, 2005; 280(27): 25436 - 25449. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Virkki, I. C. Forster, J. Biber, and H. Murer Substrate interactions in the human type IIa sodium-phosphate cotransporter (NaPi-IIa) Am J Physiol Renal Physiol, May 1, 2005; 288(5): F969 - F981. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |